The Exit of Multinational Pharmaceutical Companies from Pakistan – Part 3 – Asrar Qureshi’s Blog Post #1293

Asrar Qureshi’s blog discusses the exit of multinational pharmaceutical companies from Pakistan and the country’s potential to attract them back. Highlighting necessary reforms in pricing, regulation, and clinical research, it stresses a long-term vision for the pharmaceutical sector as vital for economic growth and public health security. Collaboration between domestic and multinational firms is essential for success.
Share
Scientist pipetting liquid into a tray in a laboratory setting with lab equipment and computer displaying graphs
View Post

Why Multinational Pharmaceutical Companies Are Leaving Pakistan – Asrar Qureshi’s Blog Post #1291

Asrar Qureshi’s blog post discusses the exit of multinational pharmaceutical companies from the Pakistani market, highlighting historical contributions, major exits, and the challenges faced by these firms, such as drug price controls and currency depreciation. Despite local companies acquiring many brands, concerns about access to innovative therapies and a decline in research presence persist.
Share
View Post

Formation of PharmEx Pakistan – Too Late, Too Little? – Asrar Qureshi’s Blog Post #1123

The Ministry of Commerce in Pakistan is launching PharmEx Pakistan to boost pharmaceutical exports, aiming to increase annual exports from $700 million to $3 billion. This public-private initiative, modeled after India’s Pharmexcil, seeks to enhance regulatory compliance and global visibility for Pakistani pharmaceuticals, while facing challenges in international competitiveness.
Share
View Post

Pharmaceutical Marketing – Stuck in the Past – Asrar Qureshi’s Blog Post #1103

The blog post discusses the stagnation of pharmaceutical marketing due to reliance on outdated strategies, regulatory constraints, and risk aversion. It emphasizes the need for innovation through data-driven personalization, omnichannel engagement, and agile methodologies. A cultural shift toward collaboration and customer-centric approaches is essential for modernization and relevance in a changing landscape.
Share
View Post

Influence of Gen AI on Pharmaceutical Marketing – Now and in Five Years – Asrar Qureshi’s Blog Post #1088

Asrar Qureshi’s blog discusses the transformative impact of Artificial Intelligence (AI) on pharmaceutical marketing, emphasizing its evolution towards more data-driven, personalized strategies. It highlights current capabilities, like AI in predictive analytics and content creation, while forecasting increased AI integration over the next five years, offering significant advantages to adaptable companies.
Share
View Post

Disruption of Careers in Pharma Industry – Asrar Qureshi’s Blog Post #1018

Asrar Qureshi’s Blog Post discusses the evolution of career paths in Pakistan’s pharmaceutical industry over the past 40 years. It highlights the shift from MNC-led promotions to local companies hiring laterally, leading to unqualified promotions and ethical challenges. The post emphasizes the industry’s declining appeal as stress and burnout increase among employees despite higher perks and salaries.
Share